Table 2.
Antidepressant | Stimulant | Antipsychotic | |||||||
---|---|---|---|---|---|---|---|---|---|
Age group | All% | Male% | Female% | All% | Male% | Female% | All% | Male% | Female% |
Younger children (3–5 years) | 0.2 | 0.2 | 0.2 | 0.5 | 0.8 | 0.3 | 0.2 | 0.3 | 0.1 |
Older children (6–12 years) | 1.0 | 1.3 | 0.8 | 4.6 | 6.8 | 2.5 | 0.8 | 1.2 | 0.4 |
Adolescents (13–18 years) | 2.8 | 2.4 | 3.2 | 3.7 | 5.1 | 2.4 | 1.2 | 1.4 | 1.0 |
Young adults (19–24 years) | 4.0 | 2.4 | 5.6 | 1.6 | 1.6 | 1.6 | 0.8 | 0.8 | 0.8 |
IMS LifeLink® Information Assets-LRx Longitudinal Prescription Database, 2008, IMS Health Incorporated.